8-K - Oncotelic Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Financing

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

, above. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description Incorporation by reference 10.1 Amendment 1 to Restricted Stock Agre

Material Agreement

Source Document

2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant See Item 1.01, above. Item 3.02 Unregistered S

Financing

Exhibits (2)

10.1

EX-10.1

8-K